Literature DB >> 23351421

The association of clinical guideline adherence and pay-for-performance among patients with diabetes.

Chiu-Ling Lai1, Ying-Hui Hou.   

Abstract

BACKGROUND: Diabetes mellitus management is one of the most challenging health care issues in Taiwan. To improve guideline adherence and the quality of diabetes care, the diabetes mellitus pay-for-performance (DM-P4P) program was introduced in 2001. This study examined the effects of the DM-P4P program on guideline adherence among patients with diabetes.
METHODS: This cross-sectional study used National Health Insurance (NHI) claim data to assess guideline adherence among three groups of patients with diabetes: patients enrolled in the DM-P4P program, patients not enrolled but treated by DM-P4P-participating physicians, and patients treated by non-P4P physicians. Guideline adherence measures included hemoglobin A1c, blood glucose, lipid, serum creatinine, alanine transaminase, urinalysis, and eye examinations. Multiple logistic regression with generalized estimated equation approach were used to assess the effect of the DM-P4P program while controlling for patient and physician characteristics.
RESULTS: A total of 520,804 patients were included in the analysis. Patients enrolled in the DM-P4P program were more likely to receive all of the guideline-recommended tests/examinations than patients treated by non-P4P physicians. Patients who were not enrolled in the program but who were treated by DM-P4P-participating physicians were more likely to receive three of the seven recommended tests/examinations than were those treated by non-P4P physicians.
CONCLUSION: When physicians participated in the P4P program, this increased the likelihood that patients would receive guideline-recommended tests or examinations. Increasing the DM-P4P participation rates for physicians and patients are important and worthwhile objectives that can assist in the effort to more effectively manage diabetes in the general population.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23351421     DOI: 10.1016/j.jcma.2012.06.024

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  12 in total

1.  Analyzing Medical Guideline Dissemination Behaviors Using Culturally Infused Agent Based Modeling Framework.

Authors:  Eunice E Santos; John Korah; Suresh Subramanian; Vairavan Murugappan; Elbert S Huang; Neda Laiteerapong; Ali Cinar
Journal:  IEEE J Biomed Health Inform       Date:  2021-06-03       Impact factor: 5.772

2.  Impact of a Comprehensive Guideline Dissemination Strategy on Diabetes Diagnostic Test Rates: an Interrupted Time Series.

Authors:  Jennica Nichols; Baiju R Shah; Priscila Pequeno; Carolyn Gall Casey; Catherine H Yu
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

3.  Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan.

Authors:  Shwu-Jiuan Sheu; Wen-Liang Lin; Yea-Huei Kao Yang; Chi-Min Hwu; Ching-Lan Cheng
Journal:  BMC Health Serv Res       Date:  2018-08-15       Impact factor: 2.655

4.  Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.

Authors:  Hsiao-Yun Hu; Feng-Xuan Jian; Yun-Ju Lai; Yung-Feng Yen; Nicole Huang; Shang Jyh Hwang
Journal:  BMJ Open       Date:  2019-09-13       Impact factor: 2.692

5.  Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.

Authors:  Chien-Wen Chou; Pei-Tseng Kung; Wen-Yu Chou; Wen-Chen Tsai
Journal:  BMJ Open       Date:  2019-10-16       Impact factor: 2.692

6.  Short-term effects of a pay-for-performance programme for diabetes in a primary care setting: an observational study.

Authors:  H Ödesjö; A Anell; S Gudbjörnsdottir; J Thorn; S Björck
Journal:  Scand J Prim Health Care       Date:  2015-12-15       Impact factor: 2.581

7.  Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?

Authors:  Huei-Ju Chen; Nicole Huang; Long-Sheng Chen; Yiing-Jenq Chou; Chung-Pin Li; Chen-Yi Wu; Yu-Chia Chang
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

8.  Effects of pay for performance on risk incidence of infection and of revision after total knee arthroplasty in type 2 diabetic patients: A nationwide matched cohort study.

Authors:  Yi-Shiun Tsai; Pei-Tseng Kung; Ming-Chou Ku; Yeuh-Hsin Wang; Wen-Chen Tsai
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

9.  Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.

Authors:  Shang-Jyh Chiou; Kuomeng Liao; Yu-Tung Huang; Wender Lin; Chi-Jeng Hsieh
Journal:  J Diabetes Investig       Date:  2020-11-07       Impact factor: 4.232

10.  Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus.

Authors:  Fang-Ping Kung; Ching-Fang Tsai; Chin-Li Lu; Li-Chung Huang; Chieh-Hsiang Lu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.